ERBB2 and breast carcinoma: In our single-institution retrospective study we evaluated the influence of classical prognostic factors and uPA and PAI-1 concentrations in breast cancer tissue on disease outcomes in HR-positive/HER2-negative node-negative breast cancer patients treated with adjuvant endocrine therapy.